The Effectiveness of Acupuncture for Complications in Critically Ill Patients
Delirium, Agitation, Arrhythmia
About this trial
This is an interventional supportive care trial for Delirium focused on measuring acupuncture, intensive care, delirium, agitation, double blinded randomized control study
Eligibility Criteria
Inclusion Criteria:
Age 20--90
- newly ICU admission (<48 hours)
- APACHE score <30
- Less than 3 inotropic medicine use
- Fi02< 60%.
Exclusion Criteria:
• Coagulopathy: Prolong Prothrombin Time (PPT) activated Partial Thromboplastin Time (aPTT) more than 4 times
- Thrombocytopenia - low platelet count
- Clinically unstable: receiving two or more inotropic agents or Fraction of Inspired Oxygen (Fi02) >60%
- Primary central nervous system disorder: stroke, traumatic brain injury, central nervous system infections, brain tumors, recent intracranial surgery
- Already under other traditional medicine intervention during hospitalization
- Skin damage of more than 20% of the body skin.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Acupuncture with press tack needle group (Acu)
Placebo group press tack placebo (Con)
Patients in acupuncture group will receive traditional Chinese acupuncture using Press Tack Needle (PYONEX 0.20 x l.5mm made by Seirin Corporation). The following acupoints will be used: HT 7 (Shen Men), PC 6 (Nei Guan), LU 9 (Tai yuan), LI 4 (He Gu), SP 3 (Tai Bai,) ST 44 (Nei ting), LIV 3 (Tai Chong). The treatment will use bilateral acupuncture Interventions will be given on day 1, 3, and 5 after patient's enrolment.
Patients randomized to the control group will receive a press lack placebo (made by Seirin Corporation), which looks identical to press tack needles but, with no needle element. The point selection will be identical to the acupuncture group: HT 7 (Shen Men), PC 6 (Nei Guan), LU 9 (Tai yuan), L1 4 (He Gu), SP 3; (Tat Bai), ST 44 (Ne1 tmg), LIV 3 (Tat Chong). Interventions will be given on days 1, 3, and 5 after the patient's enrolment.